Skip to main content

Prostate and Urologic Cancers

Conducts and supports research on the prevention and early detection of prostate and bladder cancers. Develops and supports prevention trials and evaluation of new agents, surrogate biomarkers, and emerging technologies for identifying premalignant lesions.

On This Page

All Heading 2s will automatically be pulled in to this list.
Do not edit the content on this template.

Major Programs

Staff List

Grid View

Photo	Name, Email, Phone	Room	Group(s)/Office
	Asefa, Mela mela.asefa@nih.gov 240-276-6422	5E328	Program Support Assistant \| Breast and Gynecologic Cancer Program Support Assistant \| Prostate and Urologic Cancer
	House, Margaret, RN, B.S.N. margaret.house@nih.gov 240-276-7047	5E306	Deputy Chief \| Prostate and Urologic Cancer
	Parnes, Howard L., M.D. howard.parnes@nih.gov 240-276-7045	5E302	Chief \| Prostate and Urologic Cancer

Grants

PI Name Sort descending	PI Organization	Title	Grant Number	Program Official
Wolpin, Brian Matthew	Dana-Farber Cancer Inst United States	Altered metabolism and machine learning for pancreatic cancer early detection	5U01CA210171-09	Matthew Young, Ph.D.
Wong, David T	University Of California Los Angeles United States	EFIRM Liquid Biopsy Research Laboratory: Early Lung Cancer Assessment	4U01CA233370-08	Nicholas Hodges, Ph.D.
Wright, Alexi A	Dana-Farber Cancer Inst United States	Randomized trial of REVITALIZE: A telehealth intervention to reduce fatigue interference among adults with advanced ovarian cancer on PARP inhibitors	5R01CA289547-02	Goli Samimi, Ph.D., M.P.H.
Wu, Yun	State University Of New York At Buffalo United States	Lung Cancer Early Detection and Immunotherapy Response Prediction and Monitoring with an Exo-PROS Liquid Biopsy Assay	4R01CA272827-04	Christos Patriotis, Ph.D., M.Sc.
Xiao, Yi	University Of Tx Md Anderson Can Ctr United States	Exploring new strategy for breast cancer immunoprevention by targeting histamine receptor H1	5R21CA286318-02	Anda Vlad, M.D., Ph.D.
Xu, Chunhui	Emory University United States	High-throughput assessment of chemotherapy-induced cardiotoxicity in 3D human cardiomyocytes	1R21CA285254-01A1	Eileen Dimond, R.N., M.S.
Xu, Xiangxi Mike	University Of Miami School Of Medicine United States	Countering microtubule stabilization within hair follicles in ovarian cancer chemotherapy	5R01CA286527-02	Rachel Altshuler, Ph.D.
Yaddanapudi, Kavitha	University Of Louisville United States	A Stem Cell Based Exosomal Vaccine for the Prevention of Cancer	5R21CA277314-02
Yaghjyan, Lusine	University Of Florida United States	Stromal contributions to breast carcinogenesis	5R01CA277817-03	Christos Patriotis, Ph.D., M.Sc.
Yang, Qing	University Of Texas Med Br Galveston United States	The role of acute excitation of sensory neurons in the development of paclitaxel-induced peripheral neuropathy	5R01CA273001-02	Rachel Altshuler, Ph.D.
Yang, Wan	Columbia University Health Sciences United States	UNCOVER: underlying novel causes of onset of very early cancer research	5R01CA257971-05	Nicholas Hodges, Ph.D.
Yeh, Jennifer M.	Boston Children'S Hospital United States	Can risk-reducing medications improve breast cancer prevention in childhood and adolescent cancer survivors? Comparative modeling to inform care	5R01CA261874-04	Eileen Dimond, R.N., M.S.
Yendamuri, Saikrishna	Roswell Park Cancer Institute Corp United States	Metformin for chemoprevention of lung cancer in obese subjects at high risk	5R01CA255515-05	Malgorzata Wojtowicz, M.D.
Yilmaz, Omer	Massachusetts Institute Of Technology United States	PROSPECT - Stem cell models	3OT2CA297570-01S1	Asad Umar, D.V.M., Ph.D.
You, Ming	Methodist Hospital Research Institute United States	Targeting phenethyl isothiocyanate to mitochondria in lung carcinogenesis	5R01CA280746-02	John Clifford, Ph.D.